April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Paclitaxel Modulates TGF-β1 Signaling In The Corneal Endothelium
Author Affiliations & Notes
  • Mariah A. Schumacher
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • Lezlie Jones
    School of Optometry, Indiana University, Bloomington, Indiana
  • Mahesh Shivanna
    Regenerative Biology and Medicine, IUPUI, Indianapolis, Indiana
  • Clark Springs
    Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana
  • Udaya B. Kompella
    Pharmaceutical Sciences, University of Colorado, Denver, Colorado
  • SP Srinivas
    School of Optometry, Indiana University, Bloomington, Indiana
  • Footnotes
    Commercial Relationships  Mariah A. Schumacher, None; Lezlie Jones, None; Mahesh Shivanna, None; Clark Springs, None; Udaya B. Kompella, None; SP Srinivas, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6697. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mariah A. Schumacher, Lezlie Jones, Mahesh Shivanna, Clark Springs, Udaya B. Kompella, SP Srinivas; Paclitaxel Modulates TGF-β1 Signaling In The Corneal Endothelium. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6697.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : TGF-ß family cytokines, which are found in the cornea and aqueous humor, modulate cell proliferation and fibrotic response of the corneal endothelium during wound healing. In this study, we have examined whether Smad signaling downstream of TGF-ß1 can be influenced by paclitaxel (Taxol) in the corneal endothelium.

Methods: : Cultured bovine corneal endothelial cells (BCEC) were used for all the experiments. The effect of TGF-ß on BCEC was characterized by electric cell-substrate impedance sensing (ECIS). The impedance, which is sensitive to changes in cellular morphology and breakdown of the apical junctional complex, was measured using ECIS1600R (Applied Biophysics, Inc.,Troy, NY) with cells grown on gold electrodes to an AC current of 1 µA at 4 KHz and reported as normalized transendothelial electrical resistance (TER). Cytochalasin D (1 µg/mL), an actin severing agent was used as a positive control to assess the ECIS measurements.

Results: : Cells were serum starved for an hour and then exposed to TGF-ß1 (20 ng/mL; >24 hrs; n = 6). TER, which was measured in realtime, showed a sustained decrease (17.7 + 3.4%) when compared to untreated cells. The effect of cytochalasin D (1µg/mL), which disrupts the peri-junctional actomyosin ring, on the decrease in TER was much more pronounced (> 30%) and maximum response took < 3 h. The effect of the cytokine was opposed significantly by co-treatment with paclitaxel (5 µM) at 24 hrs (TGF-ß1: 22% vs. Paclitaxel +TGF-ß1:6.22%; n = 5). Effect of elevated cAMP, which is known to oppose TGF-ß1 signaling, was tested by pre-exposure to forskolin (10 µM) + Rolipram (50 µM). This pre-treatment also reduced the effect of the cytokine (TGF-ß1: 21% vs Forskolin + Rolipram +TGF-ß1: 10%; n = 5). The cytokine also induced a noticeable disassembly of the microtubules at 3 h which was opposed by forskolin and rolipram as well as paclitaxel.

Conclusions: : Our findings suggest that the effect of TGF-ß1 can be opposed by stabilizing microtubules and by elevated cAMP in the corneal endothelium. In addition to epithelial to mesenchymal transformation associated with TGF-ß1, the cytokine also breaks down the barrier integrity of corneal endothelium as implied by the significant decrease in TER.

Keywords: cornea: endothelium • cytokines/chemokines 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×